Search / Trial NCT06233760

Prevalence of Abuse Among Patients With Rheumatic Diseases

Launched by NATIONAL INSTITUTE OF MEDICAL SCIENCES AND NUTRITION, SALVADOR ZUBIRAN · Jan 22, 2024

Trial Information

Current as of December 22, 2024

Recruiting

Keywords

Rheumatic Diseases Abuse

ClinConnect Summary

This clinical trial is studying the prevalence of abuse among patients with rheumatic diseases, which are long-lasting conditions that affect the joints and tissues in the body. The researchers want to understand how common abuse and neglect might be in this group since these patients often face challenges like needing extra care and support, which can make them more vulnerable. The study will take place in two parts: first, the researchers will adapt a tool to measure abuse specifically for these patients, and then they will use this tool to find out how many patients experience abuse and what factors might be linked to it.

To be eligible for this trial, participants must be diagnosed with a rheumatic disease by their doctor and agree to take part in the study. Unfortunately, those who do not have a confirmed diagnosis cannot participate. If you or a family member join this study, you can expect to help the researchers gather important information that could lead to better support and resources for patients facing similar challenges. This study is currently recruiting participants, and it aims to shed light on an important issue that has not been well studied before.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with a rheumatic disease diagnosis according to their primary rheumatologist who agree to participate
  • Exclusion Criteria:
  • Patients with a not confirmed rheumatic disease

Trial Officials

Virginia Dr Pascual-Ramos

Principal Investigator

INNSZ

About National Institute Of Medical Sciences And Nutrition, Salvador Zubiran

The National Institute of Medical Sciences and Nutrition Salvador Zubirán (INCMNSZ) is a premier research institution in Mexico dedicated to advancing medical science and improving public health through innovative clinical research. Renowned for its multidisciplinary approach, the institute specializes in nutrition, metabolic disorders, and chronic diseases, conducting rigorous clinical trials that contribute to evidence-based healthcare practices. With a commitment to fostering collaboration among researchers, healthcare professionals, and academic institutions, INCMNSZ plays a pivotal role in translating scientific discoveries into effective therapeutic interventions, ultimately enhancing patient outcomes and promoting health equity in the community.

Locations

Mexico City, , Mexico

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0